Cervical cancer screening in India: Strategies revisited

Indian Journal of Medical Sciences

Volumn 61, Issue 1, 2007, Pages 35-48

  Juneja, A ^a   Sehgal, A ^b   Sharma, S ^b   Pandey, A ^a  

^a INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

^b Institute of Cytology and Preventive Oncology (ICMR)   (India)

Author keywords

Cervical cancer; Human papilloma virus; Screening; Visual inspection

Indexed keywords

ACETIC ACID; LUGOL;

CANCER SCREENING; DEVELOPING COUNTRY; HUMAN; INDIA; REVIEW; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; WART VIRUS;

EID: 33845988405     PISSN: 00195359     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (61)

1. National Cancer Registry Program. Annual Report. ICMR: New Delhi; 1990-1996.
2. Koss LG, Greenebaum. Precancerous lesions. In: Bourke GF, editor. The epidemiology of cancer. Charles Press: Philadelphia; 1983. p. 31-59.
3. Miller AB, Chamberlain J, Day NE, Hakama M, Prorok PC. Report on a Workshop of the UICC Project on Evaluation of Screening for Cancer. Int J Cancer 1990;46:761-9.
4. Walton RJ. Editorial: The task force on cervical cancer screening programs. Can Med Assoc J 1976;114:981.
5. Eddy DM. Screening for cervical cancer. Ann Intern Med 1990;113:214-26.
6. Celentano DD, deLissovoy G. Assessment of cervical cancer screening and followup programs. Public Health Rev 1989;17:173-240.
7. Hakama M, Rasanen-Virtanen U. Effect of a mass screening program on the risk of cervical cancer. Am J Epidemiol 1976;103:512-7.
8. Laara E, Day NE, Hakama M. Trends in mortality from cervical cancer in the Nordic countries: Association with organized screening programs. Lancet 1987;1:1247-9.
9. Anderson GH, Boyes DA, Benedet JL, Le Riche JC, Matisic JP, Suen KC, et al. Organization and results of the cervical cytology screening program in British Columbia, 1955-85. Br Med J (Clin Res Ed) 1988;296:975-8.
10. Control of cancer of the cervix uteri. A WHO meeting. Bull World Health Organ 1986;64:607-18.
11. Miller AB. The cost effectiveness of cervical cancer screening. Ann Intern Med 1992;117:529-30.
12. Sankaranarayanan R, Thara S, Sharma A, Roy C, Shastri S, Mahe C, et al. Accuracy of conventional cytology: Results from a multicentre screening study in India. J Med Screen 2004;11:77-84.
13. Fahey MT, Irwig L, Macaskill P. Meta-analysis of Pap test accuracy. Am J Epidemiol 1995;141:680-9.
14. Miller AB. Cervical Cancer screening programs: Managerial guidelines. WHO: Geneva; 1992.
15. Directorate General of Health Services. National Cancer Control Program of India. Government of India: New Delhi; 1984.
16. Stjernsward J, Eddy D, Luthra UK, Stanley K. Plotting a new course for cervical cancer in developing countries. World Hlth Frm 1987;8:42-5.
17. Alonso de Ruiz P, Lazcano-Ponce E. Quality control in cytopathology Laboratories in six Latin American Countries. In: Weid GL, et al, editors. Comparison on Quality Assurance, Proficiency testing and workload limitations in clinical cytology. International Academy of Cytology: Chikago, Illinoi; 1995.
18. nd ed. USA: 2000.
19. Das DK, Murthy NS, Bhatnager P, Juneja A, Sharma S, Pant JN, et al. Efficacy of a hospital based cytology screening program. Neoplasma 1992;39:381-4.
20. Misra JS, Gupta HP, Das V. Assessing the feasibility of single lifetime PAP smear evaluation between 41-50 years of age as strategy for cervical cancer control in developing countries from our 32 years of experience of hospital-based routine cytological screening. Diagn Cytopathol 2004;31:376-9.
21. Luthra UK, Prabhakar AK, Seth P, Agarwal SS, Murthy NS, Bhatnagar P, et al. Natural history of precancerous and cancerous lesions of the uterine cervix. Acta Cytol 1987;31:226-34.
22. Murthy NS, Sehgal A, Satyanarayana L, Das DK, Singh V, Das BC, et al. Risk factors related to biological behaviour of precancerous lesions of the uterine cervix. Br J Cancer 1990;61:732-6.
23. Sehgal A, Singh V, Bhambhani S, Luthra UK. Screening for cervical cancer by direct inspection. Lancet 1991;338:282.
24. Singh V, Sehgal A, Luthra UK. Screening for cervical cancer by direct inspection. BMJ 1992;304:534-5.
25. Juneja A, Sehgal A, Agarwal SS, Murthy NS, Singh V, Tuteja RK, et al. Selective cervical cytology screening for a developing country. Int J Gynecol Obstet India 2002;5:53-5.
26. Juneja A, Sehgal A, Mitra AB, Pandey A. A survey on risk factors associated with cervical cancer. Indian J Cancer 2003;40:15-22.
27. Schiffman MH, Bauer HM, Hoover RN, Glass AG, Cadell DM, Rush BB, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993;85:958-64.
28. IARC working group: Summary chapter. In: Hakama M, editors. Screening for cancer of uterine cervix. IARC scientific Publication No 76. Lyon: 1986. p. 133-42.
29. Murthy NS, Agarwal SS, Prabhakar AK, Sharma S, Das DK. Estimation of reduction of life-time risk of cervical cancer through one life-time screening. Neoplasma 1993;40:255-8.
30. Juneja A, Murthy NS, Tuteja RK, Sardana S, Das DK. Reduction in the cumulative incidence rate of cervical cancer by one life time selective screening. Neoplasma 1997;44:272-4.
31. Wesley R, Sankaranarayanan R, Mathew B, Chandralekha B, Aysha Beegum A, Amma NS, et al. Evaluation of visual inspection as a screening test for cervical cancer. Br J Cancer 1997;75:436-40.
32. Bhargava VL, Verma K, Sharma R, Batra S, Anandalakshmy PN. A hospital-based study on the use of paramedical personnel for clinical downstaging of cancer cervix. Indian J Med Res 1993;98:65-8.
33. Gaffikin L, Ahmed S, Chen YQ, McGrath JM, Blumenthal PD. Risk factors as the basis for triage in low-resource cervical cancer screening programs. Int J Gynaecol Obstet 2003;80:41-7.
34. Belinson JL, Pretorius RG, Zhang WH, Wu LY, Qiao YL, Elson P. Cervical cancer screening by simple visual inspection after acetic acid. Obstet Gynecol 2001;98:441-4.
35. Sankaranarayanan R, Chatterji R, Shastri SS, Wesley RS, Basu P, Mahe C, et al. Accuracy of human papillomavirus testing in primary screening of cervical neoplasia: Results from a multicenter study in India. Int J Cancer 2004;112:341-7.
36. Wright TC Jr. Cervical cancer screening using visualization techniques. J Natl Cancer Inst Monogr 2003;31:66-71.
37. Sankaranarayanan R, Rajkumar R, Theresa R, Esmy PO, Mahe C, Bagyalakshmi KR, et al. Initial results from a randomized trial of cervical visual screening in rural south India. Int J Cancer 2004;109:461-7.
38. Parashari A, Singh V, Sehgal A, Satyanarayana L, Sodhani P, Gupta MM. Low cost technology for screening of uterine cervical cancer. Bull WHO 2000;78:964-7.
39. Blumenthal P. Discussion of aided visual inspection. In the proceedings from a working meeting on cervical cancer prevention, screening and treatment. Program for appropriate technology in health for Nicholson Street. In collaboration with AVSC International: Montreal Quebec; 1994.
40. Sankaranarayanan R, Shastri SS, Basu P, Mahe C, Mandal R, Amin G, et al. The role of low-level magnification in visual inspection with acetic acid for the early detection of cervical neoplasia. Cancer Detect Prev 2004;28:345-51.
41. Basu PS, Sankaranarayanan R, Mandal R, Roy C, Das P, Choudhury D, et al. Visual inspection with acetic acid and cytology in the early detection of cervical neoplasia in Kolkata, India. Int J Gynecol Cancer 2003;13:626-32.
42. Denny L, Kuhn L, Pollack A, Wright TC Jr. Direct visual inspection for cervical cancer screening: An analysis of factors influencing test performance. Cancer 2002;94:1699-707.
43. Sankaranarayanan R, Basu P, Wesley RS, Mahe C, Keita N, Mbalawa CC, et al. IARC Multicentre Study Group on Cervical Cancer Early Detection. Accuracy of visual screening for cervical neoplasia: Results from an IARC multicentre study in India and Africa. Int J Cancer 2004;110:907-13.
44. Shastri SS, Dinshaw K, Amin G, Goswami S, Patil S, Chinoy R, et al. Concurrent evaluation of visual, cytological and HPV testing as screening methods for the early detection of cervical neoplasia in Mumbai, India. Bull WHO 2005;83:186-94.
45. Mandelblatt JS, Lawrence WF, Gaffikin L, Limpahayom KK, Lumbiganon P, Warakamin S, et al. Costs and benefits of different strategies to screen for cervical cancer in less-developed countries. J Natl Cancer Inst 2002;94:1469-83.
46. Goldie SJ, Gaffikin L, Goldhaber-Fiebert JD, Gordillo-Tobar A, Levin C, Mahe C, et al. Cost-effectiveness of cervical-cancer screening in five developing countries. N Engl J Med 2005;353:2158-68.
47. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castlesague X, Shah KV, et al. Epidemiological classification of Human Papilloma virus types associated with cervical cancer. N Engl J Med 2003;348:518-27.
48. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002;55:244-65.
49. Cuzick J, Sasieni P, Davies P, Adams J, Normand C, Frater A, et al. A systematic review of the role of human papilloma virus (HPV) testing within a cervical screening program: Summary and conclusions. Br J Cancer 2000;83:561-5.
50. Cuzick J, Sasieni P, Davies P, Adams J, Normand C, Frater A, et al. A systematic review of the role of human papilloma virus (HPV) testing within a cervical screening program: Summary and conclusions. Br J Cancer 2000;83:561-5.
51. Monsonego J, Bosch FX, Coursaget P, Cox JT, Franco E, Frazer I, et al. Cervical cancer control, priorities and new directions. Int J Cancer 2004;108:329-33.
52. Legood R, Gray AM, Mahe C, Wolstenholme J, Jayant K, Nene BM, et al. Screening for cervical cancer in India: How much will it cost? A trial based analysis of the cost per case detected. Int J Cancer 2005;117:981-7.
53. Sellors JW, Lorincz AT, Mahony JB, Mielzynska I, Lytwyn A, Roth P, et al. Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions. CMAJ 2000;163:513-8.
54. Wright TC Jr, Denny L, Kuhn L, Pollack A, Lorincz A. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. JAMA 2000;283:81-6.
55. National Workshop on control of cervical cancer-Alternate strategies: Recommendations Institute of Cytology and Preventive Oncology (ICMR): 2001.
56. Ponten J, Adami HO, Bergstrom R, Dillner J, Friberg LG, Gustafsson L, et al. Strategies for global control of cervical cancer. Int J Cancer 1995;60:1-26.
57. Jayant K, Rao RS, Nene BM, Dale PS. Improved stage at diagnosis of cervical cancer with increased cancer awareness in a rural Indian population. Int J Cancer 1995;63:161-3.
58. Prabhakar AK. Cervical Cancer in India. Strategy for control. Indian J Cancer 1992;29:104-13.
59. Schatzkin A, Connor RJ, Taylor PR, Bunnag B. Comparing new and old screening tests when a reference procedure cannot be performed on all screenees. Example of automated cytometry for early detection of cervical cancer. Am J Epidemiol 1987;125:672-8.
60. Sodhani P, Gupta S, Singh V, Sehgal A, Halder K, Parashari A. Sensitivity of the Pap test in detecting high grade lesions: What should be the acceptable cytologic threshold for colposcopic referral? Acta Cytol 2006;50:181-4.
61. Gallioway DA. Is vaccination against HPV a possibility? Lancet 1998 351:22-4.